drugset / Trial / NCT01282684
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PLX5622 in Healthy Adult Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to study the safety and tolerability of a single dose of PLX5622 in healthy, adult human volunteers. This will be the first time PLX5622 has been taken by humans.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PLX5622 | Small molecule | 200 mg | Oral |
| Comparator | PLX5622 | Small molecule | 400 mg | Oral |
| Comparator | PLX5622 | Small molecule | 800 mg | Oral |
| Comparator | PLX5622 | Small molecule | 1000 mg | Oral |
| Comparator | PLX5622 | Small molecule | 1400 mg | Oral |
| Comparator | PLX5622 | Small molecule | 1600 mg | Oral |
Indications
No indication recorded.